The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults von Nichols, Alice I., RN, Penny Fatato, Shenouda, Magdy, Paul, Jeffrey, Isler, Jennifer A., Pedersen, Ronald D., Jiang, Qin, Ahmed, Saeeduddin, Patroneva, Albena

Volltext

Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma von Hassan, Raffit, Kindler, Hedy L, Jahan, Thierry, Bazhenova, Lyudmila, Reck, Martin, Thomas, Anish, Pastan, Ira, Parno, Jeff, O'Shannessy, Daniel J, Fatato, Penny, Maltzman, Julia D, Wallin, Bruce A

Volltext

Phase II clinical trial of amatuximab, a chimeric anti-mesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma von Hassan, Raffit, Kindler, Hedy L., Jahan, Thierry, Bazhenova, Lyudmila, Reck, Martin, Thomas, Anish, Pastan, Ira, Parno, Jeff, O’Shannessy, Daniel J., Fatato, Penny, Maltzman, Julia D., Wallin, Bruce A.

Volltext

Amatuximab, a chimeric monoclonal antibody to mesothelin, in combination with pemetrexed and cisplatin in patients with unresectable pleural mesothelioma: Results of a multicenter... von Hassan, Raffit, Jahan, Thierry Marie, Kindler, Hedy Lee, Bazhenova, Lyudmila, Reck, Martin, Pastan, Ira, Ellis, Alison, Fatato, Penny Marie, Heyburn, John, Schweizer, Charles, Parno, Jeff, Wallin, Bruce

Volltext